Watermark

BGB-290-302

Active, not recruiting

Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-290-302

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20171666

Study Overview

Sex: Female Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: Female Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents